XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Collaboration and Licensing Agreements (Tables)
3 Months Ended
Mar. 31, 2021
Collaboration and Licensing Agreements  
Schedule of revenue by licensees

The revenues recorded for the three months ended March 31, 2021 and 2020 were earned principally from the following licensees (in millions):

Three Months Ended

 

March 31, 

 

2021

2020

 

Aimmune

$

    

$

9.6

Alexion

    

5.3

3.3

Astellas

0.3

Genentech

0.2

0.7

Gilead

6.0

Janssen

14.6

MorphoSys

13.9

12.5

Total

$

34.0

$

32.4

Schedule of disaggregation of revenue

The table below summarizes the disaggregation of revenue recorded for the three months ended March 31, 2021 and 2020 (in millions):

Three Months Ended

 

March 31, 

 

2021

2020

 

Research collaboration

    

$

14.8

    

$

1.0

Milestone

12.5

 

12.5

Licensing

 

15.6

Royalties

6.7

3.3

Total

$

34.0

$

32.4